Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fuji
Healthtrust
Citi
Daiichi Sankyo
Cipla
Boehringer Ingelheim
US Army
Queensland Health

Generated: July 17, 2018

DrugPatentWatch Database Preview

QUTENZA Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Qutenza, and what generic alternatives are available?

Qutenza is a drug marketed by Acorda and is included in one NDA. There is one patent protecting this drug.

This drug has sixteen patent family members in ten countries.

The generic ingredient in QUTENZA is capsaicin. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the capsaicin profile page.
Summary for QUTENZA
Drug patent expirations by year for QUTENZA
Generic Entry Opportunity Date for QUTENZA
Generic Entry Date for QUTENZA*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage::
PATCH;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Medical Subject Heading (MeSH) Categories for QUTENZA
Synonyms for QUTENZA
(6E)-N-(4-Hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide #
(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
(6E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide
(E)-8-Methyl-N-vanillyl-6-nonenamide
(E)-8-Methyl-N-vanillyl-6-nonenamide(8cl)
(E)-Capsaicin
(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide
(E)-N-(4-Hydroxy-3-methoxybenzyl)
(e)-n-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
(E)-N-[(4-hydroxy-3-methoxy-phenyl)methyl]-8-methyl-non-6-enamide
(E)-N-[(4-Hydroxy-3-methoxyphenyl)-methyl]-8-methyl-6-nonenamide
(E)-N-[(4-HYDROXY-3-METHOXYPHENYL)METHYL]-8-METHYL-6-NONENAMIDE
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
(E)8-methyl-N-vanillyl-6-Nonenamide
[(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
1217899-52-9
404-86-4
4CH-016296
6-Nonenamide, (E)-
6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl
6-Nonenamide, 8-methyl-N-vanillyl-, (E)-
6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI)
6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (6E)-
6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)-
6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (6E)-
6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (E)-
8-Methyl-N-Vanillyl-6-Nonenamide
8-Methyl-N-vanillyl-6-nonenamide, (E)-
8-Methyl-N-vanillyl-6E-nonenamide
8-Methyl-N-vanillyl-trans-6-nonenamide
912457-62-6
AB00053098_12
AB00053098-11
AC-10114
AC1LU7K3
AC1Q46B3
Adlea
AJ-26667
AK113598
AKOS007930159
ALGRX 4975
AN-23437
Ausanil
Axsain
BBL027836
BDBM20461
BDBM86537
Bio-0615
Bitter orange extract 30%
BPBio1_001053
BRD-K37056290-001-01-1
BRD-K50590187-001-06-6
BRN 2816484
BSPBio_000957
BSPBio_001548
BSPBio_002917
BT000467
C06866
C18H27NO3
Capsaicin
CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN))
Capsaicin (8-Methyl-N-vanillyl-6-nonenamide)
Capsaicin (in oleoresin of capsicum)
Capsaicin (JAN/USP)
Capsaicin (Natural)
Capsaicin (transdermal patch formulation, neuropathic pain)
Capsaicin [in oleoresin of capsicum]
Capsaicin [USAN]
Capsaicin [USP:INN]
Capsaicin Patch
Capsaicin, >=95%, from Capsicum sp.
Capsaicin, analytical standard
Capsaicin, certified reference material, TraceCERT(R)
Capsaicin, European Pharmacopoeia (EP) Reference Standard
Capsaicin, from Capsicum sp., >=50% (HPLC)
Capsaicin, from natural source
CAPSAICIN, NATURAL
Capsaicin, pharmaceutical secondary standard; traceable to USP, PhEur
Capsaicin, United States Pharmacopeia (USP) Reference Standard
Capsaicin(Qutenza)
CAPSAICINE
CAPSAICINOIDS
Capsicin
Capsicine
CAS_404-86-4
CAS-404-86-4
Caswell No. 158
CC0144
CCG-39908
CCRIS 1588
CHEBI:3374
CHEBI:94524
CHEMBL294199
Citrus Aurantium 30%
Citrus Aurantium Extract
CITRUS AURANTIUM PE
CJ-23980
CS-1518
D00250
D0U5CE
DB06774
depletes Substance P
DSSTox_CID_241
DSSTox_GSID_20241
DSSTox_RID_75455
DTXSID9020241
E-CAPSAICIN
EI-125
EINECS 206-969-8
EPA Pesticide Chemical Code 070701
epsilon-capsaicin
FEMA No. 3404
FT-0082538
GTPL2486
HMS1361N10
HMS1570P19
HMS1791N10
HMS1921H11
HMS1989N10
HMS2089N11
HMS2092D21
HMS2097P19
HMS2230O23
HMS3402N10
HMS3649N15
HMS501B16
HSDB 954
HY-10448
I01-2469
IDI1_000354
IDI1_034018
Isodecenoate
Isodecenoic acid vanillylamide
KS-5181
LMFA08020085
LP003278
LS-2138
M1149
MCULE-8056866140
MEGxp0_001448
MFCD00017259
Mioton
MLS002154049
MolPort-001-742-263
MR3H3
N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide
N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide, (E)-
N-(3-Methoxy-4-hydroxybenzyl)-8-methyl-6-nonenamide
n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide
N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
N-[(4-hydroxy-3-methoxyphenyl)methyl]-6E-8-methyl-nonenamide
N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
N0C781
N1667
N735
NCGC00017337-02
NCGC00017337-03
NCGC00017337-04
NCGC00017337-05
NCGC00017337-06
NCGC00017337-07
NCGC00017337-08
NCGC00017337-09
NCGC00017337-10
NCGC00017337-11
NCGC00017337-12
NCGC00017337-13
NCGC00090853-01
NCGC00090853-02
NCGC00090853-03
NCGC00090853-04
NCGC00090853-06
NCGC00090853-07
NCGC00090853-08
NCGC00090853-09
NCGC00090853-10
NCGC00090853-11
NCGC00090853-12
NCGC00257869-01
NCI-C56564
neurotoxic
NGX 4010
NGX-1998
NGX-3781
NGX-4010
NGX-7325
Nonenamide, 8-methyl-N-vanillyl-, (E)-
Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8 -methyl-, (E)-
NSC 56353
NSC_2548
NSC-56353
NSC-757844
NSC56353
NSC757844
Pharmakon1600-01501128
Prestwick_204
Prestwick2_000879
Prestwick3_000879
RTC-030399
S07O44R1ZM
SBI-0052593.P002
SC-19636
SCHEMBL8085
SCHEMBL8086
SDCCGMLS-0066678.P001
SMP2_000337
SMR000718774
SPECTRUM1501128
Spectrum5_000538
SR-05000001861
SR-05000001861-6
SR-05000001861-9
ST057183
STL372889
Styptysat
TC-030399
TL8002946
TNP00277
Tox21_110817
Tox21_200315
TQ-1018
trans-8-Methyl-N-vanillyl-6-nonenamide
trans-8-Methyl-N-vanillylnon
trans-Capsaicin
trans-Capsaicin-d3
trans-N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide
Transacin
UNII-S07O44R1ZM
UPCMLD-DP092
UPCMLD-DP092:001
UPCMLD-DP092:002
Vanilloid
W-5044
YKPUWZUDDOIDPM-SOFGYWHQSA-N
ZINC1530575
Zostrix
ZOSTRIX (TN)
Zostrix HP

US Patents and Regulatory Information for QUTENZA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acorda QUTENZA capsaicin PATCH;TOPICAL 022395-001 Nov 16, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for QUTENZA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,248,788 Therapeutic method with capsaicin and capasicin analogs ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Dow
Chubb
Colorcon
Cerilliant
Moodys
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.